Position in REGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$85,424
-$20,427 QoQ
Shares Held
137
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,096
of 1,322 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MONTAG A & ASSOCIATES INC holds $1,116,311 across 17 Biotechnology names. REGN ranks #5 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
852 | $423,213 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
750 | $213,727 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
5,013 | $195,557 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
194 | $104,168 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
137 | $85,424 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
542 | $47,126 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
80 | $19,277 | |
| 8 | NKTR |
Nektar Therapeutics
|
250 | $17,452 |
All Filings in REGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,424 | 137 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $105,851 | 137 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $105,746 | 137 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $77,593 | 138 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $72,450 | 138 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $86,889 | 137 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $99,013 | 139 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $823,120 | 783 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $825,058 | 785 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $911,478 | 947 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $814,174 | 927 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $125,912 | 153 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $109,936 | 153 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $127,358 | 155 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $111,830 | 155 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $89,553 | 130 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $76,846 | 130 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $90,794 | 130 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $82,097 | 130 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $78,673 | 130 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $72,610 | 130 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $61,508 | 130 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $62,804 | 130 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||